Nutritional aspects in cystic fibrosis

European Journal of Gastroenterology and Hepatology

Volumn 8, Issue 8, 1996, Pages 739-743

  Dodge, John A ^a   O'Rawe, Angela M ^b  

^a QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Body composition; Cystic fibrosis; Energy expenditure; Macronutrient; Micronutrient; Nutrient supplementation

Indexed keywords

FATTY ACID; PROTEIN; TRACE METAL; VITAMIN;

BODY COMPOSITION; CYSTIC FIBROSIS; DIET SUPPLEMENTATION; DIET THERAPY; ENERGY BALANCE; ENERGY EXPENDITURE; GROWTH RETARDATION; HUMAN; LUNG DISEASE; MUSCLE ATROPHY; NUTRITION; PRACTICE GUIDELINE; PRIORITY JOURNAL; REVIEW;

ADULT; CHILD; CYSTIC FIBROSIS; DEFICIENCY DISEASES; ENERGY METABOLISM; GROWTH; HUMANS; NUTRITIONAL STATUS; NUTRITIONAL SUPPORT;

EID: 0029832493     PISSN: 0954691X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (57)

1. Shepherd RW, Holt TL, Greer R, Cleghorn GJ, Thomas BJ: Total body potassium in cystic fibrosis. J Pediatr Gastroenterol Nutr 1989, 9:200-205.
2. Greer R, Shepherd R, Cleghorn G, Bowling FG, Holt T: Evaluation of growth and changes in body composition following neonatal diagnosis of cystic fibrosis. J Pediatr Gastroenterol Nutr 1991, 13:52-58.
3. Gurwitz D, Corey M, Francis PWJ, Crozier D, Levison H: Perspectives in cystic fibrosis. Pediatr Clin North Am 1979, 26:603-615.
4. Kraemer R, Rudeberg A, Hadorn B, Rossi E: Relative underweight in cystic fibrosis and its prognostic value. Acta Paediatr Scand 1978, 67:33-37.
5. Luder E, Kattan M, Thornton JC, Koehler KM, Bonforte RJ: Efficacy of a nonrestricted fat diet in patients with cystic fibrosis. Am J Dis Child 1989, 143:458-464.
6. Shepherd RW, Holt TL, Thomas BJ, Kay L, Isles A, Francis PJ, et al.: Nutritional rehabilitation in cystic fibrosis: controlled studies of effects on nutritional growth retardation, body protein turnover and course of pulmonary disease. J Pediatr 1986, 109:788-794.
7. Gaskin KJ, Waters DL, Baur LA, Soutter VL, Gruca MA: Nutritional status, growth and development in children undergoing intensive treatment for cystic fibrosis. Acta Paediatr Scand 1990, 336(suppl.):106-110.
8. Corey M, McLaughlin FJ, Williams M, Levison H: A comparison of survival, growth and pulmonary function in patients with cystic fibrosis in Boston and Toronto. J Clin Epidemiol 1988, 41:588-591.
9. Soutter VL, Kristidis P, Gruca MA, Gaskin KJ: Chronic undernutrition/growth retardation in cystic fibrosis. Clin Gastroenterol 1986, 15:137-146.
10. Sproul A, Huang N: Growth patterns in children with cystic fibrosis. J Pediatr 1991, 118:865-872.
11. Mearns, MB: The heights of CF patients aged 2-9 years allowing for parental height and severity of pulmonary episodes from birth. In Perspectives in Cystic Fibrosis. Edited by Sturgess JM. The Imperial Press; 1980:262-265.
12. Dodge JA, Yassa JG: Food intake and supplementary feeding programmes. Proceedings of the 9th International Congress on Cystic Fibrosis. 1980:125-36.
13. Marcus MS, Sondel SA, Farrell PM, Laxova A, Carey PM, Langhough R, et al.: Nutritional status of infants with cystic fibrosis associated with early diagnosis and intervention. Am J Clin Nutr 1991, 54:578-585.
14. Surana R, Puri P: Small intestinal atresia: effect on fetal nutrition. J Pediatr Surg 1994, 29(9):1250-1252.
15. Morrison JM, O'Rawe AM, McCracken KJ, Redmond AOB, Dodge JA: Energy intakes and losses in cystic fibrosis. J Hum Nutr Dietetics 1994, 7:39-46.
16. Shepherd RW, Thomas BJ, Bennett D, Cooksley WGE, Ward LC: Changes in body composition and muscle protein degradation during nutritional supplementation in nutritionally growth-retarded children with cystic fibrosis. J Pediatr Gastroenterol Nutr 1983, 2:439-446.
17. Sokol RJ, Reardon MC, Accurso FJ, Stall C, Narkewicz M, Abman SH, et al.: Fat-soluble vitamin status during the first year of life in infants with cystic fibrosis identified by screening of newborns. Am J Clin Nutr 1989, 50:1064-1071.
18. Abman SH, Accurso FJ, Bowman CM: Persistent morbidity and mortality of protein calorie malnutrition in young infants with cystic fibrosis. J Pediatr Gastroenterol Nutr 1986, 5:393-396.
19. Johnston JL, Leong MS, Checkland EG, Zuberbuhler PC, Conger PR, Quinney HA, et al.: Body fat assessed from body density and estimated from skinfold thickness in normal children and children with cystic fibrosis. Am J Clin Nutr 1988, 48:1362-1366.
20. Spicher V, Roulet M, Schutz Y: Assessment of total energy expenditure in free living patients with cystic fibrosis. J Pediatr 1991, 118:865-872.
21. Bland JM, Altman DG: Statistical methods for assessing agreement between two methods of clinical measurement. Lancet 1986, i:307-310.
22. Borowitz D, Conboy K: Are bioelectric impedance measurements valid in patients with cystic fibrosis? J Pediatr Gastroenterol Nutr 1994, 18(4):453-456.
23. Newby MJ, Keim NL, Brown DL: Body composition of adult cystic fibrosis patients and control subjects as determined by densitometry, bioelectric impedance, total-body electrical conductivity, skinfold measurements and deuterium oxide dilution. Am J Clin Nutr 1990, 52:209-213.
24. Lapey A, Kattwinkel J, di Sant'Agnese PA, Laster L: Steatorrhea and azotorrhea and their relation to growth and nutrition in adolescents and young adults with cystic fibrosis. Pediatrics 1974, 84:328-334.
25. Murphy JL, Wootton SA, Bond SA, Jackson AA: Energy content of stool in normal healthy controls and patients with cystic fibrosis. Arch Dis Child 1991, 66:495-500.
26. Vaisman N, Pencharz PB, Corey M Canny GJ, Haln E: Energy expenditure of patients with cystic fibrosis. J Pediatr 1987, 111:496-500.
27. Buchdahl RM, Cox M, Fulleylove C, Marchant JL, Tomkins AM, Brueton MJ, et al.: Increased resting energy expenditure in cystic fibrosis. J Appl Physiol 1988, 64(5):1801-1806.
28. Shepherd RW, Holt TL, Vasques-Velasquez L, Coward WA, Prentice A, Lucas A: Increased energy expenditure in children with cystic fibrosis. Lancet 1988, i:1300-1303.
29. O'Rawe A, McIntosh I, Dodge JA, Brock DJH, Redmond AOB, Ward R, et al.: Increased energy expenditure in cystic fibrosis is associated with specific mutations. Clin Sci 1992, 82:71-76.
30. Fried MD, Durie PR, Tsui L-S, Corey M, Levison H, Pencharz PB: The cystic fibrosis gene and energy expenditure. J Pediatr 1991, 119:913-916.
31. Durie PR, Pencharz PB: A rational approach to the nutritional care of patients with cystic fibrosis. J R Soc Med 1989, 82(suppl. 16):11.
32. Bogardus C, Lillioja S, Ravussin E, Abbot W, Zawadzki JK, Young A, et al.: Familial dependence of the resting metabolic rate. N Engl J Med 1986, 315:96-100.
33. Bouchard C, Tremblay A, Nadeau A, et al.: Genetic effect in resting and exercise metabolic rates. Metabolism 1989, 38(4):364-370.
34. Bronstein MN, Davies PS, Hambidge KM, Accurso FJ: Normal energy expenditure in the infant with presymptomatic cystic fibrosis. J Pediatr 1995, 126(1):28-33. The doubly labelled water method was used to measure total energy expenditure (TEE) in 19 presymptomatic CF infants, (0.8-6.6 months old). Genotype characterized and energy balance also assessed. There was no observed difference in TEE between these and healthy infants.
35. Tomezsko JL, et al.: Energy expenditure and genotype of children with CF. Pediatr Res 1994, 35:451-460. Total (TEE) and resting (REE) energy expenditure were determined in 25 well prepubertal CF patients with mild-moderate lung disease, and 25 healthy controls. The CF group had a 9% increase in REE with no evidence of significant effect of genotype or pulmonary function. TEE was increased by 12% in the entire CF group and by 23% in the DF508 CF subgroup compared with controls. This is at variance with previous reports of normal TEE in CF. Further studies of detailed physical activity indices in CF subjects in various genotypic groups are indicated.
36. Sridhar MK: Why do patients with emphysema lose weight? Lancet 1995, 345:1190-1191.
37. Elborn JS, Norman D, Delamere FM, Shale DJ: In vitro tumour necrosis factor-alpha secretion by monocytes from patients with cystic fibrosis. Am J Respir Cell Mol Biol 1992, 6:207-211.
38. Wilson DO, Rogers RM, Hoffman RM: Nutrition and chronic lung disease. Am Rev Respir Dis 1985, 132:1347-1365.
39. Goldstein S, Askanazi J, Weissman C, Thomashow B, Kinney JM: Energy expenditure in patients with chronic obstructive pulmonary disease. Chest 1987, 91:222-224.
40. Kane RE, Hobbs PJ, Black PG: Comparison of low, medium and high carbohydrate formulas for night-time enterai feedings in cystic fibrosis patients. J Parenteral Enteral Nutr 1990, 14(1):47-52.
41. Reardon MC, et al.: Nutritional deficits exist before 2 months of age in some infants with cystic fibrosis identified by screening test. J Pediatr 1984, 105:271-274.
42. Rayner RJ, et al.: Night blindness and conjunctival xerosis caused by vitamin A deficiency in patients with cystic fibrosis. Arch Dis Child 1989, 64:1151-1156.
43. Mischler EH, et al.: Nutritional assessment of infants with cystic fibrosis diagnosed through screening. Pediatr Pulmonol 1991.
44. Carlstedt-Duke J, Bronnegard M, Strandvik B: Pathological regulation of arachidonic acid release in cystic fibrosis: the putative basic defect. Proc Natl Acad Sci 1986, 83:9202-9206.
45. Kurlandsky LE, et al.: The absorption and effect of dietary supplementation with omega-3 fatty acids on serum leukotriene B4 in patients with cystic fibrosis. Pediatr Pulmonol 1994, 18:211-217. Management of EFA deficiency in CF has been to supplement with predominantly omega-6 fatty acids (particularly linoleic acid). However, as a precursor of the eicosanoid leukotriene LBT4, it has been hypothesized that use of omega-6 fatty acids may augment the levels of inflammatory mediators. In attempting to attenuate such a response, dietary supplementation with omega-3 fatty acids has been used preferentially. The result was a significant reduction in serum LBT4. A therapeutic role for the anti-inflammatory effects of omega-3 fatty acids in CF management is as yet unclear.
46. Ramsey BW, Farrell PM, Pencharz P and the Consensus Committee: Nutritional assessment and management in cystic fibrosis: a consensus report. Am J Clin Nutr 1992, 55:108-116.
47. Ater JL, Herbst JJ, Landaw SA, O'Brien RT: Relative anemia and iron deficiency in cystic fibrosis. Pediatrics 1983, 71:810-814.
48. van-Caille-Bertrand M, et al.: Trace metals in cystic fibrosis. Acta Paediatr Scand 1982, 71:203-207.
49. Neve J, et al.: Plasma and erythrocyte zinc, copper and selenium in cystic fibrosis. Acta Paediatr Scand 1983, 72:437-440.
50. Dworkin B, et al.: Low blood selenium levels in patients with cystic fibrosis compared to controls and healthy adults. J Parenteral Enteral Nutr 1987, 11:38-41.
51. Gauntt C, Tracy S: Deficient virus evokes nasty heart virus. Nature Med 1995, 1:405-406.
52. Pencharz PB: Energy intakes and low-fat diets in children with cystic fibrosis [editorial]. J Pediatr Gastroenterol Nutr 1983, 2:400-402.
53. Thomson MA, Bucolo S, Quirk P, Shepherd RW: Measured versus predicted resting energy expenditure in infants: a need for reappraisal. J Pediatr 1995, 126(1):21-27. The reliability of commonly used predictive equations for estimating energy expenditure in infants both in health and in disease was assessed. Compared with measured values, predicted values for CF patients were underestimated. It suggested re-examination of currently used formulae.
54. Murphy MD, Ireton-Jones CS, Hillman BC, Gorman MA, Liepa GU: Resting energy expenditures measured by indirect calorimetry are higher in preadolescent children with cystic fibrosis than energy expenditures calculated from prediction equations. J Am Diet Assoc 1995, 95(1):30-33. Thirty-one preadolescent CF patients had measurement made of resting energy expenditure. Harris Benedict equations and CF Consensus Committee equations underestimated energy expenditures by 13% and 8% respectively.
55. Cabrera ME, Lough MD, Doershuk CF, Salvator AE: An expanded scoring system including an index of nutritional status for patients with cystic fibrosis. Pediatr Pulmonol 1994, 18(4):199-205. Assessment of 21 CF patients using an expanded scoring system based on nutritional and pulmonary function indices. This multiparameter score was felt to provide an effective and sensitive index of disease severity and is advocated in measuring effect of intervention and disease progression.
56. Stark LJ, Jelalian E, Mulvihill MM, Powers SW, Bowen AM, Spieth LE, et al.: Eating in preschool children with cystic fibrosis and healthy peers: behavioural analysis. Pediatrics 1995, 95(2):210-215. Calorie intake, eating styles and parental perceptions of eating behaviour in 32 CF children aged 2-5 years were compared with 29 healthy peers. The observation confirmed previous findings that CF children tend to eat as much as or more than their peers but are not meeting CF recommendations. There were also behavioural differences in eating and parental perception of children's eating that may influence sub-optimal nutrient intakes.
57. Stark LJ, Powers SW, Jelalian E, Rape RN, Miller DL: Modifying problematic mealtime interactions of children with cystic fibrosis and their parents via behavioural training. J Pediatr Psychol 1994, 19(6):751-768. Behavioural intervention demonstrated to be successful in managing feeding problems in CF children, improvements in behaviour and weight gain observed.